Tanenbaum Molly L, Commissariat Persis V, Wilmot Emma G, Lange Karin
Division of Endocrinology, Gerontology, and Metabolism, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Section on Clinical, Behavioral, and Outcomes Research, Joslin Diabetes Center, Boston, MA, USA.
J Diabetes Sci Technol. 2025 Jan;19(1):47-53. doi: 10.1177/19322968241275963. Epub 2024 Aug 30.
Advances in diabetes technologies have enabled automated insulin delivery (AID) systems, which have demonstrated benefits to glycemia, psychosocial outcomes, and quality of life for people with type 1 diabetes (T1D). Despite the many demonstrated benefits, AID systems come with their own unique challenges: continued user attention and effort, barriers to equitable access, personal costs vs benefits, and integration of the system into daily life. The purpose of this narrative review is to identify challenges and opportunities for supporting uptake and onboarding of AID systems to ultimately support sustained AID use. Setting realistic expectations, providing comprehensive training, developing willingness to adopt new treatments and workflows, upskilling of diabetes team members, and increasing flexibility of care to tailor care to individual needs, preferences, lifestyle, and personal goals will be most effective in facilitating effective, widespread, person-centered implementation of AID systems.
糖尿病技术的进步催生了自动胰岛素输送(AID)系统,该系统已证明对1型糖尿病(T1D)患者的血糖水平、心理社会结局和生活质量有益。尽管有诸多已证实的益处,但AID系统也有其独特的挑战:需要用户持续关注和付出努力、存在公平获取的障碍、个人成本与收益的问题,以及将系统融入日常生活。本叙述性综述的目的是确定支持AID系统采用和入门的挑战与机遇,以最终支持AID系统的持续使用。设定现实的期望、提供全面的培训、培养采用新治疗方法和工作流程的意愿、提升糖尿病团队成员的技能,以及增加护理的灵活性以根据个体需求、偏好、生活方式和个人目标量身定制护理,将最有效地促进AID系统以患者为中心的有效、广泛实施。